Hyloris Pharmaceuticals SA (EBR:HYL)

Hyloris Pharmaceuticals Revenue

Hyloris Pharmaceuticals had revenue of 3.34M EUR in the half year ending June 30, 2025, with 74.54% growth. This brings the company's revenue in the last twelve months to 8.46M, up 30.42% year-over-year. In the year 2024, Hyloris Pharmaceuticals had annual revenue of 9.76M with 159.64% growth.

• Revenue (ttm): 8.46M
• Revenue Growth: +30.42%
• P/S Ratio: 19.40
• Revenue / Employee: 169.18K
• Employees: 49
• Market Cap: 164.08M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.76M	6.00M	159.64%
Dec 31, 2023	3.76M	1.37M	57.48%
Dec 31, 2022	2.39M	-709.00K	-22.90%
Dec 31, 2021	3.10M	2.92M	1,669.14%
Dec 31, 2020	175.00K	84.00K	92.31%